FDA has increased unannounced inspections of foreign API manufacturers and is also stepping up Remote Inspections via FDA form 4003
For example, the current recommendations for the management of children with Kawasaki disease include treatment with high-dose aspirin in the acute phase, and low-dose aspirin during the period of thrombocytosis
Studies show that, on average, adults using semaglutide lost about 35 poundsabout 15% of their body weight
Against the backdrop of anticipated double-digit health care cost increases, fueled to a large degree by GLP-1s and overall prescription drug costs, companies cannot ignore the reality that GLP-1s have significant implications for health care budgetsand overall affordability. Further price increases on the horizon With the coming availability of GLP-1 weight loss medications that can be taken orally, 87% of responding employers reported that they expect higher demand from workers, and the vast majority expect the monthly price for prescriptions to only rise
When the FDA declared a national shortage of semaglutide, a GLP-1 receptor agonist, in March 2022, compounding pharmacies gained legal permission to produce custom versions of Novo Nordisks key ingredient in Ozempic and Wegovy
